Clik here to view.
Acelity Launches PREVENA PLUS™ Incision Management System with Customizable...
SAN ANTONIO Acelity, a global wound care and regenerative medicine company, today announced the expansion of its PREVENA™ Therapy portfolio with the global launch of the PREVENA PLUS™ Incision...
View ArticleClik here to view.
GORE® VIABAHN®内假体庆贺20载可靠功效
亚利桑那州弗拉格斯塔夫 (美国商业资讯) — W. L. Gore & Associates, Inc. (Gore)正在庆贺GORE® VIABAHN®内假体上市20周年，这种市场领先的支架-移植物用于治疗复杂型周围血管疾病。该器械经过工程设计，可有效覆盖和封堵病变组织，为医生处治挑战性的复杂型病灶提供管腔内旁路选择。该器械于1996年率先在欧洲植入，以往的名称是GORE®...
View ArticleClik here to view.
“MEMSセンシング&ネットワークシステム展と同時開催”最先端の光技術、未来に向けてAll about Photonics 2016 まもなく開幕
東京 （ビジネスワイヤ） — 株式会社JTBコミュニケーションデザインは、フォトニクスの総合展示会＆カンファレンス「All about Photonics 2016」とナノ マイクロビジネス展リニューアル開催となる「MEMSセンシング&ネットワークシステム展」を、9月14日（水）～16日（金）の3日間、パシフィコ横浜にて開催いたします。...
View ArticleClik here to view.
Samsung Bioepis’ SB4 (BRENZYS™) Becomes First Etanercept Biosimilar to...
INCHEON, Korea Samsung Bioepis Co., Ltd. today announced that BRENZYS™ – a biosimilar referencing Enbrel® (etanercept), also known as SB4 – received regulatory approval in Canada for the treatment...
View ArticleClik here to view.
Takeda Supports Global Expansion of the American Cancer Society’s Relay For...
NEW YORK, & OSAKA, Japan The American Cancer Society (ACS) and Takeda Pharmaceutical Company Limited (TSE:4502) today announced that Takeda will support the projected expansion of the ACS’s...
View ArticleClik here to view.
Takeda and PRA Health Sciences Announce Transformational Clinical Development...
OSAKA, Japan & RALEIGH, N.C. PRA Health Sciences, Inc. (NASDAQ: PRAH) and Takeda Pharmaceutical Company Limited (TSE: 4502) announced today that the companies have entered into a new partnership...
View ArticleClik here to view.
GORE® VIABAHN® Endoprosthesisが定評のある性能を提供して20年
米アリゾナ州フラッグスタッフ （ビジネスワイヤ） — W. L. Gore & Associates, Inc.（ゴア）は、複雑な末梢血管疾患の治療に使用するステントグラフトとして市場をリードするGORE® VIABAHN®...
View ArticleClik here to view.
Starpharma: VivaGel® Condom Receives Regulatory Approval in Canada
MELBOURNE, Australia Starpharma Holdings Ltd (ASX: SPL) (OTCQX: SPHRY) today announced it had been granted a medical device license for the VivaGel® condom by the Canadian regulatory authority,...
View ArticleClik here to view.
Dr. Reddy’s Listed on Dow Jones Sustainability Indices 2016
HYDERABAD, India Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) has been listed as an Index component of the Dow Jones Sustainability Indices (DJSI) 2016 in the...
View ArticleClik here to view.
Ignyta to Present at 2016 Silicon Valley Bank Healthcare Capital and...
SAN DIEGO Ignyta, Inc. (Nasdaq: RXDX), a biotechnology company focused on precision medicine in oncology, announced today that Jacob Chacko, M.D., its Chief Financial Officer, will make a...
View ArticleClik here to view.
10x Genomics Accelerates Asia Pacific Expansion with Japanese Distributor...
PLEASANTON, Calif. 10x Genomics, Inc., a company focused on expanding genomics applications by providing researchers with access to critical longrange genomic information and gene expression at...
View ArticleClik here to view.
Dr. Reddy’s Expands Strategic Collaboration with Amgen in India
HYDERABAD, India Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) today announced that it has expanded its strategic collaboration with Amgen, one of the world’s leading...
View ArticleClik here to view.
Takeda Receives Positive CHMP Opinion for Conditional Approval of NINLAROTM...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE: 4502) announced today that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP)...
View ArticleClik here to view.
Dr. Reddy’s Laboratories Announces the Launch of Paricalcitol Injection in...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has launched Paricalcitol Injection, USP, in 2 mcg, 5 mcg, 10 mcg,...
View ArticleClik here to view.
Clik here to view.
生物制药业认为，联合国药品可及性高级别小组的建议错失了真正回应患者需求的良机
日内瓦 –(美国商业资讯)–生物制药业认为，在应对影响数百万人能否获取他们需要的药品及疫苗的紧要议题上，联合国药品可及性高级别小组(UN High Level Panel on Access to Medicines,...
View ArticleClik here to view.
GORE® TAG®胸主动脉血管内覆膜支架的枢纽性研究完成首例植入
亚利桑那州弗拉格斯塔夫 (美国商业资讯) — W. L. Gore & Associates, Inc. (Gore)今天宣布，GORE® TAG®胸主动脉血管内覆膜支架(TBE)的枢纽性研究完成首例植入。入组该例患者的是Himanshu Patel, MD，他是密西根大学佛兰克尔心血管中心成人心脏外科的分科主任和该研究的联席全国主要研究者。 Smart News...
View ArticleClik here to view.
Takeda and Zydus Cadila partner to address the global threat of Chikungunya
OSAKA, Japan & AHMEDABAD, India Takeda Pharmaceutical Company Limited [TSE: 4502], (“Takeda”) and Zydus Cadila today announced a partnership to tackle chikungunya, an emerging infectious disease...
View ArticleClik here to view.
GORE® VIABAHN® Endoprosthesisが複雑なSFA疾患の治療で最適なデバイスであることを日本での臨床研究の1年成績が確認
米アリゾナ州フラッグスタッフ & ラスベガス （ビジネスワイヤ） — W. L. Gore & Associates, Inc.（ゴア）は本日、GORE® VIABAHN® Endoprosthesis with Heparin Bioactive...
View ArticleClik here to view.
日本临床研究1年结果证实，GORE® VIABAHN®血管内覆膜支架是治疗SFA复杂型病变的首选器械
亚利桑那州弗拉格斯塔夫和拉斯维加斯 (美国商业资讯) — W. L. Gore & Associates, Inc. (Gore)今天发布了配备肝素生物活性涂层*的GORE®...
View Article